Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOLERO-1: Everolimus with Trastuzumab and Paclitaxel in HER2+ Advanced Breast Cancer
NCT00876395Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2009
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 28
01
Overview
A Phase 3 trial of everolimus in breast cancer, sponsored by Novartis. Started Sep 2009; status: completed.
02
Drugs
everolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00876395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00876395.